Skip to content
 

SmallCap Round Up: Microsaic, Argos Resources, Proteome Sciences

*

It’s been another disappointing session for London’s junior market. The AIM Index has materially underperformed both the main board and most other European markets to leave the All Share off a further five points by the bell at 755.51.

  • Microsaic +40%
  • Argos Resources +22%
  • Proteome Sciences +19%
  • Physiomics -50%
  • Univision -40%

Microsaic [LON:MSYS] took a pummelling yesterday off the back of a cash call threat, but bargain hunters moved back in on Tuesday and helped recover at least some of the downside. The stock say 40% higher at the bell but there’s no change to the fundamentals here however with regard to the cashflow position. Separately management have tipped that audited results will be published this week too, so this could serve to sustain price action.


Argos Resources [LON:ARG] added 22% on the day to find itself in second place. However there’s not much to see here and the move is well within the quoted spread as the company plots a course towards delisting.

Proteome Sciences [LON:PRM] advanced 19% to take the notable mention. The closing spread of 17% needs to be considered here too, but the stock has made solid progress, doubling in value over the quarter and approaching levels not seen for two years. There’s no formal news out and orders were limited.

Physiomics [LON:PYC] slipped 50% on the day leaving the company at the foot of the board after it announced a funding move. The shift reflects the dilution effect of the new capital.

Univision [LON:UVEL] was the second biggest faller, off 40%. Shares in the Hong Kong based CCTV manufacturer only returned from a trading suspension last week which itself saw some heavy discounting. Trade was exceptionally limited and there’s no formal news out, but with security flaws amongst Chinese industry peers being flagged in the media, will bargain hunters be tempted in at some point?

Like this article? Sign up to our free newsletter.

This article does not constitute investment advice. Do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
FP Markets
Pepperstone
WisdomTree
CME Group
Back To Top